Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Item No. 45590
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Activin receptor type IIB (ACTRIIB) is a type II activin receptor and member of the TGF-β receptor superfamily.1,2 It is composed of an extracellular ligand-binding domain, a transmembrane domain, an intracellular kinase domain, and a C-terminal tail.2 ACTRIIB is ubiquitously expressed in fetal development with the highest expression in the brain and spinal cord and is enriched in adult skeletal muscle.3,4 ACTRIIB has several ligands, including activins, growth differentiation factor 8 (GDF8), also known as myostatin, and bone morphogenetic proteins (BMPs).2 Upon ligand binding, ACTRIIB forms a complex with type I activin receptors, which results in their activation and signaling via the SMAD pathway. ACTRIIB is involved in hematopoiesis, myogenesis, and bone formation and resorption.5 Mutations in the gene encoding ACTRIIB, ACVR2B, are associated with left-right axis malformations.6 Cayman’s ACTRIIB Rabbit Monoclonal Antibody (Clone 037) can be used for ELISA.
WARNING This product is not for human or veterinary use.
1. Activation of signalling by the activin receptor complex. Mol. Cell. Biol. 16(3), 1066-1073 (1996).
2. Activin Receptor Signaling. Encyclopedia of Hormones 17-23 (2003).
3. Expression of type II activin receptor genes during differentiation of human K562 cells and cDNA cloning of the human type IIB activin receptor. Blood 83(8), 2163-2170 (1994).
4. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Int. J. Biochem. Cell Biol. 45(10), 2333-2347 (2013).
5. Principles of the activin receptor signaling pathway and its inhibition. Cytokine Growth Factor Rev. 60, 1-17 (2021).
6. Left-